Boston Biotech Business Development Conference

Boston Biotech Business Development Conference

Speaking Engagement
The Boston Biotech Business Development Conference is a networking forum for industry professionals offering exclusive access to key decision-makers who influence deal-making and investment in the life sciences. Attendees will gain insights from presentations and panels featuring business development decision-makers from several of the world's leading pharmaceutical and biotechnology companies on the current and future outlook for licensing, M&A and other business development activities in the life sciences sector. In addition to sharing insights on what it takes to get a deal done in biotech, the conference will also offer opportunities to network one-on-one with the industry's top deal makers, including senior executives from biotech and pharma, leaders from Wall Street and venture capitalists.

WilmerHale Partner Hal Leibowitz will moderate a panel titled “M&A Activity in 2013: Who Benefits Most, Pharma or Biotech?” on Tuesday, April 2 from 4–4:30 p.m., and WilmerHale Partner David Redlick will moderate a panel titled “The Deals of Tomorrow: Predictions and Wish Lists” on Wednesday, April 3 from 3–3:30 p.m.

Read More About the Event

Speakers

You May Be Interested In

IX Oxford Arbitration Day

November 21, 2025
Speaking Engagement

International Chamber of Commerce, Young Arbitration and ADR Forum

December 3, 2025
Speaking Engagement

ACI's 42nd Annual Conference on FCPA and Global Anti-Corruption

December 3-4, 2025
Sponsorship
View all Events

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link. (The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel